ICU MEDICAL INC/DE Operating Lease, Right-of-Use Asset, Amortization Expense
ICU MEDICAL INC/DE (ICUI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $8.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $3.96M, a 18.00% decline year-over-year.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $4.17M, a 6.75% decline year-over-year.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $3.51M, a 34.18% decline year-over-year.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $4.43M, a 19.20% decline year-over-year.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for fiscal 2025 was $17.25M, a 19.18% decline from fiscal 2024.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for fiscal 2024 was $21.34M, a 2.58% decline from fiscal 2023.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for fiscal 2023 was $21.91M, a 7.36% decline from fiscal 2022.
- ICU MEDICAL INC/DE operating lease, right-of-use asset, amortization expense for fiscal 2022 was $23.65M, a 146.52% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.14M 10-Q · filed 2026-08-06 | $11.65M derived: sum of 3 quarters · filed 2026-08-06 | $16.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.17M 10-Q · filed 2026-05-07 | $7.68M derived: sum of 2 quarters · filed 2026-05-07 | $12.12M derived: sum of 3 quarters · filed 2026-05-07 | $16.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.94M derived: sum of 2 quarters · filed 2026-02-19 | $12.78M derived: sum of 3 quarters · filed 2026-08-06 | $17.25M 10-K · filed 2026-02-19 |
| 2025-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.26M derived: sum of 2 quarters · filed 2026-08-06 | $13.74M 10-Q · filed 2025-11-06 | $19.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.31M 10-Q · filed 2026-08-06 | $14.64M derived: sum of 3 quarters · filed 2026-08-06 | $20.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $4.47M 10-Q · filed 2026-05-07 | $9.81M derived: sum of 2 quarters · filed 2026-05-07 | $15.29M derived: sum of 3 quarters · filed 2026-05-07 | $20.48M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.82M derived: sum of 2 quarters · filed 2026-02-19 | $16.00M derived: sum of 3 quarters · filed 2026-02-19 | $21.34M 10-K · filed 2026-02-19 |
| 2024-09-30 | $5.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.67M derived: sum of 2 quarters · filed 2025-11-06 | $16.01M 10-Q · filed 2025-11-06 | $21.38M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $5.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.52M 10-Q · filed 2025-08-07 | $15.89M derived: sum of 3 quarters · filed 2026-02-19 | $21.32M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $5.34M 10-Q · filed 2025-05-08 | $10.71M derived: sum of 2 quarters · filed 2026-02-19 | $16.14M derived: sum of 3 quarters · filed 2026-02-19 | $21.59M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.80M derived: sum of 2 quarters · filed 2026-02-19 | $16.25M derived: sum of 3 quarters · filed 2026-02-19 | $21.91M 10-K · filed 2026-02-19 |
| 2023-09-30 | $5.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $10.89M derived: sum of 2 quarters · filed 2024-11-12 | $16.54M 10-Q · filed 2024-11-12 | $22.81M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $11.11M 10-Q · filed 2024-08-07 | $17.38M derived: sum of 3 quarters · filed 2025-02-27 | $23.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $5.66M 10-Q · filed 2024-05-07 | $11.93M derived: sum of 2 quarters · filed 2025-02-27 | $18.42M derived: sum of 3 quarters · filed 2025-02-27 | $24.02M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.76M derived: sum of 2 quarters · filed 2025-02-27 | $18.36M derived: sum of 3 quarters · filed 2025-02-27 | $23.65M 10-K · filed 2025-02-27 |
| 2022-09-30 | $6.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $12.10M derived: sum of 2 quarters · filed 2023-11-06 | $17.38M 10-Q · filed 2023-11-06 | $19.81M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $10.89M 10-Q · filed 2023-08-07 | $13.32M derived: sum of 3 quarters · filed 2024-02-27 | $15.70M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $5.29M 10-Q · filed 2023-05-09 | $7.71M derived: sum of 2 quarters · filed 2024-02-27 | $10.10M derived: sum of 3 quarters · filed 2024-02-27 | $12.51M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.81M derived: sum of 2 quarters · filed 2024-02-27 | $7.22M derived: sum of 3 quarters · filed 2024-02-27 | $9.59M 10-K · filed 2024-02-27 |
| 2021-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $4.79M derived: sum of 2 quarters · filed 2022-11-07 | $7.17M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.78M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $2.37M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $9.22M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |